FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

Conditions: Advanced Solid Tumor Interventions: Drug: FT825; Drug: Fludarabine; Drug: Cyclophosphamide; Drug: Bendamustine; Drug: Docetaxel; Drug: Cisplatin; Drug: Cetuximab Sponsors: Fate Therapeutics Recruiting

https://clinicaltrials.gov/study/NCT06241456

Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials